admin – Page 3136 – Get News Story

Hemophilia with Inhibitor Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Suzhou Alphamab Co., Catalyst Biosciences, Jiangsu Gensciences, BioMarin Pharma

The Key Hemophilia with Inhibitor Companies in the market include – Suzhou Alphamab Co., Ltd., Catalyst Biosciences, Jiangsu Gensciences lnc., Children’s Hospital Los Angeles, BioMarin Pharmaceutical, Staidson (Beijing) Biopharmaceuticals Co., Pfizer, and others.

DelveInsight’s “Hemophilia with Inhibitor Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hemophilia with Inhibitor, historical and forecasted epidemiology as well as the Hemophilia with Inhibitor market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

The latest healthcare forecast report provides an in-depth analysis of Hemophilia with Inhibitor, offering comprehensive insights into the Hemophilia with Inhibitor revenue trends, prevalence, and treatment landscape. The report delves into key Hemophilia with Inhibitor statistics, highlighting the current and projected market size, while examining the efficacy and development of emerging Hemophilia with Inhibitor therapies. Additionally, we cover the landscape of Hemophilia with Inhibitor clinical trials, providing an overview of ongoing and upcoming studies that are poised to shape the future of Hemophilia with Inhibitor treatment. This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the Hemophilia with Inhibitor space.

To Know in detail about the Hemophilia with Inhibitor market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hemophilia with Inhibitor Market Forecast

Some of the key facts of the Hemophilia with Inhibitor Market Report:

The Hemophilia with Inhibitor market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
Key Hemophilia with Inhibitor Companies: Suzhou Alphamab Co., Ltd., Catalyst Biosciences, Jiangsu Gensciences lnc., Children’s Hospital Los Angeles, BioMarin Pharmaceutical, Staidson (Beijing) Biopharmaceuticals Co., Pfizer, and others
Key Hemophilia with Inhibitor Therapies: KN057, Coagulation Factor VIIa variant, SS109, Feiba, Valoctocogene roxaparvovec, STSP-0601 for Injection, PF-06741086, and others
The Hemophilia with Inhibitor market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hemophilia with Inhibitor pipeline products will significantly revolutionize the Hemophilia with Inhibitor market dynamics.
Hemophilia A is more common than Hemophilia B, and inhibitors develop more frequently in Hemophilia A patients
Approximately 20–30% of Hemophilia A patients and 1–5% of Hemophilia B patients develop inhibitors
The United States accounts for the largest diagnosed population of hemophilia with inhibitors among the 7MM
In the EU5 (Germany, France, Italy, Spain, UK), Germany reports one of the highest numbers of hemophilia with inhibitor cases

Hemophilia with Inhibitor Overview

Hemophilia with Inhibitor is a condition where individuals with hemophilia (usually Hemophilia A or B) develop antibodies, called inhibitors, against the clotting factor (factor VIII or IX) used in their treatment. These inhibitors neutralize the infused clotting factor, making standard replacement therapy ineffective. This leads to more severe and difficult-to-control bleeding episodes, requiring alternative treatments such as bypassing agents or immune tolerance therapy. Managing hemophilia with inhibitors is more complex, costly, and carries higher health risks compared to hemophilia without inhibitors.

Get a Free sample for the Hemophilia with Inhibitor Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/hemophilia-with-inhibitor-market

Hemophilia with Inhibitor Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Hemophilia with Inhibitor Epidemiology Segmentation:

The Hemophilia with Inhibitor market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

Total Prevalence of Hemophilia with Inhibitor
Prevalent Cases of Hemophilia with Inhibitor by severity
Gender-specific Prevalence of Hemophilia with Inhibitor
Diagnosed Cases of Episodic and Chronic Hemophilia with Inhibitor

Download the report to understand which factors are driving Hemophilia with Inhibitor epidemiology trends @ Hemophilia with Inhibitor Epidemiology Forecast

Hemophilia with Inhibitor Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hemophilia with Inhibitor market or expected to get launched during the study period. The analysis covers Hemophilia with Inhibitor market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Hemophilia with Inhibitor Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Hemophilia with Inhibitor Therapies and Key Companies

KN057: Suzhou Alphamab Co., Ltd.
Coagulation Factor VIIa variant: Catalyst Biosciences
SS109: Jiangsu Gensciences lnc.
Feiba: Children’s Hospital Los Angeles
Valoctocogene roxaparvovec: BioMarin Pharmaceutical
STSP-0601 for Injection: Staidson (Beijing) Biopharmaceuticals Co.
PF-06741086: Pfizer

Discover more about therapies set to grab major Hemophilia with Inhibitor market share @ Hemophilia with Inhibitor Treatment Landscape

Hemophilia with Inhibitor Market Drivers

Advancements in bypassing agents and non-factor therapies (e.g., emicizumab) improving treatment outcomes
Increased awareness and early detection of inhibitors among hemophilia patients
Ongoing research and development in gene therapies and novel monoclonal antibodies
Rising healthcare spending and supportive reimbursement policies in key markets

Hemophilia with Inhibitor Market Barriers

High cost of advanced therapies and limited affordability in low-income regions
Complex manufacturing processes for biologics, affecting supply and access
Regulatory challenges in approving innovative or gene-based treatments
Limited long-term safety and efficacy data for newer therapies

Scope of the Hemophilia with Inhibitor Market Report

Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Hemophilia with Inhibitor Companies: Suzhou Alphamab Co., Ltd., Catalyst Biosciences, Jiangsu Gensciences lnc., Children’s Hospital Los Angeles, BioMarin Pharmaceutical, Staidson (Beijing) Biopharmaceuticals Co., Pfizer, and others
Key Hemophilia with Inhibitor Therapies: KN057, Coagulation Factor VIIa variant, SS109, Feiba, Valoctocogene roxaparvovec, STSP-0601 for Injection, PF-06741086, and others
Hemophilia with Inhibitor Therapeutic Assessment: Hemophilia with Inhibitor current marketed and Hemophilia with Inhibitor emerging therapies
Hemophilia with Inhibitor Market Dynamics: Hemophilia with Inhibitor market drivers and Hemophilia with Inhibitor market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Hemophilia with Inhibitor Unmet Needs, KOL’s views, Analyst’s views, Hemophilia with Inhibitor Market Access and Reimbursement

To know more about Hemophilia with Inhibitor companies working in the treatment market, visit @ Hemophilia with Inhibitor Clinical Trials and Therapeutic Assessment

Table of Contents

1. Hemophilia with Inhibitor Market Report Introduction

2. Executive Summary for Hemophilia with Inhibitor

3. SWOT analysis of Hemophilia with Inhibitor

4. Hemophilia with Inhibitor Patient Share (%) Overview at a Glance

5. Hemophilia with Inhibitor Market Overview at a Glance

6. Hemophilia with Inhibitor Disease Background and Overview

7. Hemophilia with Inhibitor Epidemiology and Patient Population

8. Country-Specific Patient Population of Hemophilia with Inhibitor

9. Hemophilia with Inhibitor Current Treatment and Medical Practices

10. Hemophilia with Inhibitor Unmet Needs

11. Hemophilia with Inhibitor Emerging Therapies

12. Hemophilia with Inhibitor Market Outlook

13. Country-Wise Hemophilia with Inhibitor Market Analysis (2019–2032)

14. Hemophilia with Inhibitor Market Access and Reimbursement of Therapies

15. Hemophilia with Inhibitor Market Drivers

16. Hemophilia with Inhibitor Market Barriers

17. Hemophilia with Inhibitor Appendix

18. Hemophilia with Inhibitor Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hemophilia with Inhibitor Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Suzhou Alphamab Co., Catalyst Biosciences, Jiangsu Gensciences, BioMarin Pharma

Ampcast Insiders Review and Demo Uncovers New Organic Traffic Breakthrough with AI Automation

“Turns a single idea into 8 content formats and publishes across 300+ sites within 72 hours promising true multi-channel visibility without paid ads.”

A new Ampcast Insiders Review spotlights AmpCast, an AI-driven content marketing platform that turns a single idea into 8 content formats and publishes across 300+ sites within 72 hours promising true multi-channel visibility without paid ads. With a distribution reach of over 100 billion monthly visits and a 60-day results-based guarantee, AmpCast is gaining attention as a breakthrough for marketers, agencies, and entrepreneurs seeking smarter, scalable ways to grow organic traffic in 2025.

As brands compete for attention in an increasingly crowded digital landscape, one platform is quietly gaining traction among content marketers, agencies, and entrepreneurs seeking smarter ways to reach audiences without relying solely on paid ads.

In a newly released Ampcast Insiders Review, a detailed look at the AI-powered multi-channel content marketing platform, curiosity is mounting around whether Ampcast could be the missing piece in the organic traffic puzzle for 2025 and beyond.

Developed by the team behind AmpiFire, Chris Munch and Jay Cruiz. AmpCast is described as a “revolutionary multi-channel content marketing platform” that aims to ensure your brand is “Everywhere. Instantly.” Its bold promise: take a single idea and automatically transform it into 8 unique content formats, then distribute that content across 300 plus platforms and websites all within 72 hours.

“AmpCast simplifies the complex process of content marketing through its three-step automated workflow,” notes Fabio, who walks viewers through a full demo in the video.

But what’s generating even more buzz is the platform’s expansive distribution network, which spans digital publications, blogs, podcast directories, video channels, and social media platforms a reach that reportedly totals over 100 billion monthly visits. While the review avoids overstatement, it invites viewers to consider what true multi-channel omnipresence could mean for brand growth.

“Each content format is strategically designed to maximize reach and engagement across different audience preferences and platform algorithms.”

In contrast to the time-consuming manual grind many marketers face, Ampcast leans heavily into automation and repurposing a single topic idea can be repackaged into press releases, social posts, articles, infographics, slideshows, and more. For busy professionals, the appeal lies in the shift from execution to strategy.

Video walk through can be found at: https://youtu.be/neShUEoKqhs

Notably, AmpCast is positioned as more than an update to AmpiFire. It introduces enhanced AI, expanded distribution (including users’ personal social media accounts), and a stronger emphasis on real audience growth versus mere content volume. The review hints at use cases for ecommerce stores, local businesses, coaches, agencies, and even affiliate marketers who are tired of fighting algorithms and ad fatigue.

The platform also makes an unusual offer in an era of risk-averse digital buying: a 60-daytrial backed by a results-based money-back guarantee. If users follow recommended usage and don’t see measurable increases in organic reach or traffic, they can request a refund.

Additionally, the video reveals a bundle of bonus resources offered to new users through a specific referral link.

While the review doesn’t make grand claims, it raises meaningful questions for businesses and marketers reflecting on their 2025 growth strategy:

Can content automation and multi-channel reach finally deliver consistent traffic and visibility—without the high cost of advertising? Is Ampcast the evolution of content marketing workflows we’ve been waiting for?

Those curious to explore the platform in action can view the full Ampcast Insiders Review, walkthrough, and bonus details here at:

https://fabrecommendsit.com/AmpcastDemoAndBonuses

Media Contact
Company Name: Fab Recommends It
Contact Person: Fabio Mastrocola
Email: Send Email
Country: Australia
Website: https://fabrecommendsit.com/AmpcastDemoAndBonuses

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Ampcast Insiders Review and Demo Uncovers New Organic Traffic Breakthrough with AI Automation

Diamond Blackfan Anemia Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA

DelveInsight’s “Diamond Blackfan Anemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Diamond Blackfan Anemia, historical and forecasted epidemiology as well as the Diamond Blackfan Anemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

The latest healthcare forecast report provides an in-depth analysis of Diamond Blackfan Anemia, offering comprehensive insights into the Diamond Blackfan Anemia revenue trends, prevalence, and treatment landscape. The report delves into key Diamond Blackfan Anemia statistics, highlighting the current and projected market size, while examining the efficacy and development of emerging Diamond Blackfan Anemia therapies. Additionally, we cover the landscape of Diamond Blackfan Anemia clinical trials, providing an overview of ongoing and upcoming studies that are poised to shape the future of Diamond Blackfan Anemia treatment. This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the Diamond Blackfan Anemia space.

To Know in detail about the Diamond Blackfan Anemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Diamond Blackfan Anemia Market Forecast

Some of the key facts of the Diamond Blackfan Anemia Market Report:

The Diamond Blackfan Anemia market size was valued ~USD 1.56 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
Among the EU4 countries and the UK, Germany held the largest Diamond Blackfan anemia market size, estimated at around USD 0.06 million, followed by the United Kingdom.
In 2023, corticosteroids led the Diamond Blackfan anemia treatment market, generating USD 1.1 million in revenue, outperforming other therapies like red blood cell transfusions and hematopoietic stem cell transplantation.

Key Diamond Blackfan Anemia Companies: Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA, and others
Key Diamond Blackfan Anemia Therapies: Deferasirox, and others
The Diamond Blackfan Anemia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Diamond Blackfan Anemia pipeline products will significantly revolutionize the Diamond Blackfan Anemia market dynamics.
In 2023, around 7,870 diagnosed cases of Diamond Blackfan anemia were recorded across the seven major markets (7MM), with the United States accounting for roughly 70% of these cases.
In 2023, Germany recorded the highest number of Diamond Blackfan anemia cases among the EU4 countries and the UK, with the UK following, contributing to 20% of the total diagnosed prevalent cases in these areas.
In the United States, about 46% of Diamond Blackfan anemia cases reported in 2023 were linked to mutations in the RPS19 gene. This notable prevalence is attributed to the gene’s crucial function in ribosomal protein production.

Diamond Blackfan Anemia Overview

Diamond Blackfan Anemia (DBA) is a rare inherited bone marrow disorder where the body fails to produce enough red blood cells, leading to severe anemia. It typically presents in infancy or early childhood with symptoms like fatigue, pale skin, and poor growth. Many patients may also have physical abnormalities, such as facial features, thumb or limb defects, and heart problems. DBA is often caused by mutations in genes affecting ribosome production. Treatment usually includes corticosteroids, regular blood transfusions, and in some cases, bone marrow transplantation. Ongoing research is exploring gene therapies and other targeted treatments for DBA.

Get a Free sample for the Diamond Blackfan Anemia Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/diamond-blackfan-anemia-dba-aase-syndrome-market

Diamond Blackfan Anemia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Diamond Blackfan Anemia Epidemiology Segmentation:

The Diamond Blackfan Anemia market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

Total Prevalence of Diamond Blackfan Anemia
Prevalent Cases of Diamond Blackfan Anemia by severity
Gender-specific Prevalence of Diamond Blackfan Anemia
Diagnosed Cases of Episodic and Chronic Diamond Blackfan Anemia

Download the report to understand which factors are driving Diamond Blackfan Anemia epidemiology trends @ Diamond Blackfan Anemia Epidemiology Forecast

Diamond Blackfan Anemia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diamond Blackfan Anemia market or expected to get launched during the study period. The analysis covers Diamond Blackfan Anemia market uptake by drugs, patient uptake by therapies, and sales of each drug.

The report also covers the Diamond Blackfan Anemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Diamond Blackfan Anemia Therapies and Key Companies

Deferasirox: Novartis

Discover more about therapies set to grab major Diamond Blackfan Anemia market share @ Diamond Blackfan Anemia Treatment Landscape

Diamond Blackfan Anemia Market Drivers

Rising awareness of rare genetic disorders and improved diagnostic capabilities
Advancements in gene therapy and novel targeted treatments under development
Increasing research funding and orphan drug designations encouraging innovation
Growing patient advocacy and support networks driving demand for better therapies
Availability of stem cell and bone marrow transplant techniques improving patient outcomes

Diamond Blackfan Anemia Market Barriers

Limited patient population due to the ultra-rare nature of the disease, reducing commercial incentive
High treatment costs, especially for gene therapies and transplants, creating access challenges
Complex regulatory approval pathways for rare disease therapies
Lack of long-term safety and efficacy data for emerging treatments

Scope of the Diamond Blackfan Anemia Market Report

Study Period: 2020–2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Diamond Blackfan Anemia Companies: Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA, and others
Key Diamond Blackfan Anemia Therapies: Deferasirox, and others
Diamond Blackfan Anemia Therapeutic Assessment: Diamond Blackfan Anemia current marketed and Diamond Blackfan Anemia emerging therapies
Diamond Blackfan Anemia Market Dynamics: Diamond Blackfan Anemia market drivers and Diamond Blackfan Anemia market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Diamond Blackfan Anemia Unmet Needs, KOL’s views, Analyst’s views, Diamond Blackfan Anemia Market Access and Reimbursement

To know more about Diamond Blackfan Anemia companies working in the treatment market, visit @ Diamond Blackfan Anemia Clinical Trials and Therapeutic Assessment

Table of Contents

1. Diamond Blackfan Anemia Market Report Introduction

2. Executive Summary for Diamond Blackfan Anemia

3. SWOT analysis of Diamond Blackfan Anemia

4. Diamond Blackfan Anemia Patient Share (%) Overview at a Glance

5. Diamond Blackfan Anemia Market Overview at a Glance

6. Diamond Blackfan Anemia Disease Background and Overview

7. Diamond Blackfan Anemia Epidemiology and Patient Population

8. Country-Specific Patient Population of Diamond Blackfan Anemia

9. Diamond Blackfan Anemia Current Treatment and Medical Practices

10. Diamond Blackfan Anemia Unmet Needs

11. Diamond Blackfan Anemia Emerging Therapies

12. Diamond Blackfan Anemia Market Outlook

13. Country-Wise Diamond Blackfan Anemia Market Analysis (2020–2034)

14. Diamond Blackfan Anemia Market Access and Reimbursement of Therapies

15. Diamond Blackfan Anemia Market Drivers

16. Diamond Blackfan Anemia Market Barriers

17. Diamond Blackfan Anemia Appendix

18. Diamond Blackfan Anemia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Diamond Blackfan Anemia Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA

Rolando’s HVAC, an HVAC Company in Town ‘n’ Country, FL, Tackles Aging AC Systems Before Summer Hits

“Rolando’s HVAC, an HVAC Company in Town ‘n’ Country, FL, Tackles Aging AC Systems Before Summer Hits”

FL, USA – As the summer heat approaches, many homeowners in the Tampa Bay area are preparing their homes for the sweltering temperatures. However, Rolando’s HVAC, a leading HVAC company in FL, is urging residents to address their aging air conditioning systems before the season arrives. With years of experience in air conditioning repair, maintenance, and installation, Rolando’s HVAC ensures that HVAC systems operate at peak efficiency when it matters most.

Rolando’s HVAC now carries the Google Guarantee badge, confirming its licensing, insurance, and strong customer satisfaction record. Homeowners can also explore seasonal service discounts and financing options available now.

Why Regular Air Conditioning Maintenance is Essential for Florida Homes

Florida homeowners know that air conditioning is a must for year-round comfort. As temperatures soar, keeping an AC unit in top condition becomes more important than ever. Rolando’s HVAC highlights the significance of proactive air conditioning maintenance, emphasizing that routine inspections, ac maintenance and tune-ups can prevent costly repairs and unexpected breakdowns. By scheduling air conditioning maintenance before the summer heatwave, homeowners can avoid uncomfortable surprises and ensure their AC unit is ready to perform.

One Tampa Bay homeowner recently shared his experience after his ac serviced and a seasonal system inspection:

Michael G., Tampa: “I’ve been using Rolando’s HVAC for years now, and I couldn’t be more pleased. They offer excellent customer service, and every technician I’ve worked with has been knowledgeable and efficient. I recently had my AC unit inspected and serviced by them before the summer heat kicked in, and they made sure everything was working perfectly. Their service is always top-notch!”

Comprehensive AC Repair and Maintenance Services in Town ‘n’ Country

Rolando’s HVAC provides a full range of air conditioning services, including AC repair, maintenance, and installation. Its fully licensed technicians are experts in handling a variety of HVAC units and ensure that all services are performed to the highest industry standards. Homeowners who need air conditioning services can rely on Rolando’s HVAC experts for timely and professional solutions that address everything from minor repairs to complete system replacements.

Emergency Repairs for Aging HVAC Systems

When an air conditioning system fails unexpectedly, it can quickly make a home unbearable. Rolando’s HVAC offers emergency repairs to ensure that homeowners don’t have to suffer in the heat. Their experienced HVAC technicians are available to provide prompt and reliable repairs, whether it’s a minor issue or a more complex malfunction.

One Town ‘n’ Country resident shared how fast response made a difference:

Sarah B.:“After a few sweltering days, I realized my AC was no longer keeping up with the heat. I called Rolando’s HVAC for a quick fix, and they came out right away. The technician diagnosed the problem and had it repaired in no time. The team’s professionalism and the quality of their work is why I trust them with my HVAC needs.”

Energy-Efficient Installations and Expanded HVAC Services

In addition to repairs, Rolando’s HVAC offers energy-efficient HVAC system installations to help homeowners reduce utility costs and enhance home comfort. The company also installs heat pumps and high-efficiency air conditioners that support long-term energy savings.

Rolando’s HVAC is a full-service provider, offering heating and cooling services year-round. With Florida’s unpredictable weather, their HVAC team helps homeowners maintain comfort regardless of the season.

Their licensed HVAC technicians specialize in system performance and energy efficiency, delivering reliable installation and repair solutions across the Tampa Bay area.

Trusted HVAC Company in Town ‘n’ Country, FL

With a strong reputation for quality work and responsiveness, Rolando’s HVAC continues to be a reliable HVAC company in Town ‘n’ Country, FL. Homeowners across the Tampa Bay area trust their team for air conditioning and heating services.

Rolando’s HVAC offers priority service for emergency repairs and repair discounts to help homeowners save on essential services. Whether it’s a routine AC inspection or a complex HVAC repair, the company’s technicians are dedicated to delivering high-quality work at affordable prices.

Schedule Your HVAC Service Today

As summer approaches, homeowners in Town ‘n’ Country and the greater Tampa Bay area should prepare their homes for rising temperatures. Rolando’s HVAC is ready to assist with air conditioning repairs, system installations, and maintenance services. Homeowners can schedule an appointment by visiting the company’s website or contacting its customer service team.

About Rolando’s HVAC

Rolando’s HVAC is a fully licensed Town ‘n’ Country HVAC company. It offers a wide range of services, including air conditioning repair, heating system services, and electrical services. For more information, visit rolandoshvac.com.

Media Contact
Company Name: Rolando’s H.V.A.C., LLC
Contact Person: Rolando Mojarrieta
Email: Send Email
Phone: (813) 373 6804
Address:5117 W Rio Vista Ave
City: Tampa
State: FL, 33634
Country: United States
Website: https://www.rolandoshvac.com/tampa/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Rolando’s HVAC, an HVAC Company in Town ‘n’ Country, FL, Tackles Aging AC Systems Before Summer Hits

Top Real Estate Listing Agent in La Canada Flintridge, CA, Expands Services At Keller Williams After Strategic Career Transition

La Canada Flintridge, CA – Omar Bardumyan, a real estate agent in La Canada Flintridge, CA and a well-known figure in the local real estate community, continues to enhance his service offerings following his strategic move to Keller Williams Real Estate Services in 2015. This career transition, which came after seven successful years with Town & Ranch Realty, has enabled Bardumyan to leverage additional resources while maintaining his signature personalized approach.

The move represented a pivotal moment in Bardumyan’s professional journey, connecting him with the largest real estate franchise in the nation while allowing him to maintain his deep roots in the La Canada Flintridge community.

“Joining Keller Williams was a deliberate choice to better serve my clients,” Bardumyan explains. “The additional technology, training, and networking opportunities have significantly enhanced what I can offer as a real estate listing agent in La Canada Flintridge, CA without sacrificing the personal touch that clients expect.”

Having grown up in the Foothills region, Bardumyan brings an insider’s perspective to his work as a Realtor agent in La Canada Flintridge, CA. This local knowledge, combined with his professional expertise, creates a unique value proposition for clients navigating important real estate decisions.

“Every property has a story, and every client has specific needs,” says Bardumyan. “My role as a Realtor in La Canada Flintridge, CA is to connect those elements effectively while managing the complex logistics that go into successful transactions.”

Since obtaining his license in 2008, Bardumyan has built his reputation on consistently exceeding client expectations. His practice emphasizes clear communication, strategic thinking, and meticulous attention to detail – qualities that have made him one of the most sought-after Realtors in La Canada Flintridge, CA.

“The real estate landscape continues to evolve, and I’m committed to evolving with it,” Bardumyan notes. “What remains constant is my dedication to achieving optimal outcomes for the people who trust me with their real estate goals.”

Prospective clients interested in working with Bardumyan can explore his services and approach by visiting https://omarbardumyan.kw.com/ or contacting his office to schedule a personalized consultation.

Media Contact
Company Name: Omar Bardumyan | Real Estate Agent in La Cañada CA
Contact Person: Omar Bardumyan
Email: Send Email
Phone: +1 818 600 1787
Address:848 Foothill Blvd.
City: La Cañada Flintridge
State: California
Country: United States
Website: https://omarbardumyan.kw.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Top Real Estate Listing Agent in La Canada Flintridge, CA, Expands Services At Keller Williams After Strategic Career Transition

GNFEI Technology Co., Ltd Introduces Advanced SPOT-A4-PRO UV Printer for Precision Cylinder and Flatbed Printing

GNFEI Technology Co., Ltd announces the launch of its innovative SPOT-A4-PRO A4 UV printer, engineered for high-quality, versatile printing on both cylindrical and flat surfaces, empowering businesses with enhanced customization capabilities.

GNFEI Technology Co., Ltd., a leader in advanced inkjet printing solutions, today unveiled its latest innovation, the SPOT-A4-PRO A4 UV printer. This cutting-edge machine is designed to meet the growing demand for versatile and high-precision printing on a wide array of substrates, including challenging cylindrical objects. The SPOT-A4-PRO represents a significant step forward in compact printing technology, offering businesses of all sizes the ability to expand their product customization services and explore new market opportunities with vibrant, durable, and detailed prints.

GNFEI Technology Co., Ltd

The newly launched SPOT-A4-PRO is a powerful UV printer that excels in direct-to-object printing. Its advanced LED UV curing system ensures instant ink drying, resulting in sharp, high-resolution images and text on materials such as plastic, glass, metal, wood, and acrylic. Specifically engineered for adaptability, this A4 model includes a robust mechanism for handling both flat items and cylindrical products like bottles, tubes, and cups. This dual capability makes it an ideal solution for businesses producing promotional items, personalized gifts, and bespoke industrial components, offering exceptional print quality and adhesion.

Further enhancing its versatility, the SPOT-A4-PRO functions effectively as a UV DTF printer when used with A/B films. This process allows for the creation of high-quality transfer stickers that can be applied to a multitude of surfaces, including those that are irregular or difficult to print on directly. The UV DTF capability opens up new avenues for product decoration, enabling vibrant, full-color designs with excellent durability and scratch resistance. This feature is particularly beneficial for intricate designs on items where direct printing might be challenging, providing flexibility and superior aesthetic results.

As a comprehensive UV printing machine, the SPOT-A4-PRO is built for efficiency and ease of use. Its compact footprint makes it suitable for various work environments, from small workshops to larger production facilities. The machine supports intuitive software for seamless design integration and print management, allowing users to quickly transition from concept to finished product. GNFEI’s commitment to robust engineering ensures reliability and consistent performance, empowering businesses to meet tight deadlines and deliver high-quality customized products to their clients with confidence and precision.

GNFEI Technology Co., Ltd is confident that the SPOT-A4-PRO A4 UV printer will set a new benchmark in the compact digital printing sector. By combining direct-to-object UV printing with UV DTF capabilities, this machine offers unparalleled flexibility and quality. It empowers users to unlock creative potential and cater to diverse customer demands for personalized and uniquely branded items. This launch underscores GNFEI’s dedication to innovation and providing its global clientele with state-of-the-art printing solutions that drive growth and efficiency in an evolving market.

About GNFEI Technology Co., Ltd.

GNFEI Technology Co., Ltd is a pioneering enterprise in advanced inkjet printing solutions, known for developing and manufacturing high-performance printers for diverse applications, including UV, DTF, and DTG technologies, serving a global market for over a decade.

Media Contact
Company Name: GNFEI Technology Co., Ltd
Contact Person: William
Email: Send Email
Phone: +852-57495795
State: Hong Kong
Country: China
Website: http://www.gnfei.com

Brenmiller Energy: A Thermal Energy Storage Play Hiding in Plain Sight ($BNRG)

As part of our ongoing coverage of the thermal energy storage (TES) sector, we again turn our focus to Brenmiller Energy (NASDAQ: BNRG). Not because we’re repeating ourselves—but because the market still hasn’t caught up to the reality.

In a space dominated by concept-stage ventures and flashy presentations, Brenmiller stands alone as the only pure-play publicly traded TES provider delivering results now. Not projections. Not prototypes. Fully-deployed, sovereign-backed commercial systems already reshaping how industrial energy is stored, distributed, and decarbonized.

And if you think no one’s watching TES—think again.

Speculative capital has flooded into private companies like Rondo Energy, currently valued at over $500 million, despite having only a handful of commercial deployments. While they report further tests underway, returns for deep-pocketed backers remain a question mark.

Following Brenmillers Lead

That’s not a knock on Rondo. Their tech might prove useful. However, there is little public validation to point to yet. Even Brenmiller acknowledges it will take a consortium of TES players to meet what could become a trillion-dollar market over the next decade. Everyone should be rooting for success across the board.

But let’s not ignore the obvious. Brenmiller Energy is the brand delivering TES today.

What makes this especially compelling is that Brenmiller has real traction. Its upcoming Tempo Beverage milestone (expected this July), a €7 million commitment from the European Hydrogen Bank as part of the €25 million SolWinHy Cádiz project, and over $40 million in deployed infrastructure all point to a company firing on multiple operational cylinders.

Yet its market cap hovers around just $5 million. Shares are trading at roughly $0.50.

That valuation gap isn’t just striking—it’s absurd.

Why does it exist? Likely because institutional capital can’t build a meaningful stake in Brenmiller without taking control. With only around 12 million shares outstanding, there’s simply not enough float to create the kind of returns they need at scale. That leaves the opportunity wide open for retail investors. Based on the price-to-projects-to-pipeline ratio, Brenmiller stock may be one of the most glaring disconnects on the NASDAQ.

Earning The Spotlight

Getting attention hasn’t been easy. Rondo is the poster child for buzz—with bold vision major names like Bill Gates and other big hitters behind it. While Rondo’s future may pan out, the present still belongs to Brenmiller.

Consider this: Brenmiller’s bGen™ system has already been validated across Europe, the Middle East, and the Americas. It stores industrial-scale heat using crushed rocks and discharges it on demand—24/7/365—for steam, hot air, or process heat. Current clients include Tempo Beverage, ENEL, Entelio, Green Enesys, and Viridi. Plenty more are lined up.

In other words, this isn’t a “build it and they will come” story. Brenmiller built it. And customers came.

Their latest validation? The European Hydrogen Bank’s €25 million award to the SolWinHy Cádiz green methanol project in Spain. Of that, €7 million is earmarked specifically for Brenmiller’s bGen™ units. The project will run fully off-grid, powered by solar, wind, green hydrogen, and stabilized by Brenmiller’s storage.

From Pipeline to Inflection

Beyond Spain, Brenmiller has reported a commercial pipeline exceeding $500 million, roughly $200 million of that in Europe. These aren’t abstract conversations—they’re real deals, many in engineering phases. The Tempo Beverage deployment in Israel is a key near-term milestone. It’s another high-profile proof point of TES delivering cost savings, emission reductions, and reliability in real-world industry. Most importantly, from an investor’s perspective— a near-term value driver.

Now zoom out.

As reported by CNBC on May 27, Europe is reversing its resistance to nuclear energy. Countries like Germany, Denmark, and Spain are re-integrating nuclear into their energy mix. The U.S. is following suit. New executive orders from the Trump administration have fast-tracked small modular reactors (SMRs) and cleared red tape for nuclear infrastructure.

But nuclear has a known flaw—it doesn’t scale output with demand. These plants are built for baseload generation. That’s where TES becomes indispensable.

Brenmiller’s bGen™ fills this gap. It allows nuclear facilities to operate at full capacity, storing surplus energy as heat and then releasing it to meet peak demand or support industrial users. It’s the critical link between baseload generation and variable grid needs.

Even better—Brenmiller already has nuclear-adjacent experience through its partnership with Enel, Europe’s largest utility by customer count and a global renewables pioneer. That gives Brenmiller a first-mover advantage as the next wave of nuclear infrastructure takes off.

The Market’s Backwards Logic

So here we are. Rondo Energy—minimal revenues, few deployments, and a speculative roadmap—gets a $500 million+ valuation. Meanwhile, Brenmiller, with sovereign-funded projects, multi-continent operations, and verified industrial customers, is worth just $5 million?

Markets aren’t always rational in the short term. That’s why prices swing. However, in the long term, execution and fundamentals prevail. And when they do, it’s the early believers—not the latecomers—who benefit most.

Still Hiding in Plain Sight

This isn’t our first write-up on Brenmiller. And it won’t be our last. Because in a sector drowning in hype, one company is already delivering.

It works. We are simply working to level the playing field. Yes, retail investors can capitalize on TES and potentially reap a substantial return on their investment. Perhaps not the billions in return like Gates, et al., but still plenty to change a portfolio.

The infrastructure is real. Revenues are materializing. The pipeline is growing. And the catalysts—like Tempo and SolWinHy—are within sight. Most importantly, Brenmiller’s core tech solves one of the most urgent global energy challenges: storing and dispatching heat sustainably.

Yes, Brenmiller Energy is still flying under the radar. But that’s changing. Markets are waking up to the true value of a company that isn’t theorizing change—it’s driving it. If speculative favorites stumble or fail to meet expectations, Brenmiller could become the TES sector’s re-rated frontrunner overnight.

And right now, it’s still hiding in plain sight. Based on headlines, it won’t much longer.

Disclaimers and Disclosures:Hawk Point Media Group, LLC. (HPM) has not been compensated to produce and distribute this content. It should be expressly understood that HPM is not operated by a licensed broker, a dealer, or a registered investment adviser. It should also be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. HPM reports/releases are commercial advertisements and are for general information purposes ONLY. The information made available by HPM is not intended to be, nor does it constitute, investment advice or recommendations. The contributors do NOT buy and sell securities covered before or after any particular article, report and/or publication. HPM holds ZERO shares in Brenmiller Energy Ltd. Always do your own due diligence prior to investing in any publicly traded company. While HPM has not been compensated for creating and syndicating this content, HPM discloses having a prior services agreement with the company, and third parties, that expired in April 2025 and 2024, respectively. HPM is a digital marketing and consulting company. Therefore, it is possible that HPM will be retained in the future to create and syndicate digital content for Brenmiller Energy. Accordingly, while fact-based and sourced, our content may portray featured companies in only the most favorable way. A complete disclosure for all services provided and compensated for is linked below. Forward-Looking Statements: This article contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Statements that are not statements of historical fact may be deemed to be forward-looking statements. The forward-looking statements contained or implied in this article are subject to other risks and uncertainties, many of which are beyond the control of the Company featured or HPM. Hawk Point Media Group, Llc. undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. For Hawk Point Media Group Llc’s full disclaimer and disclosure statement, click HERE.

Media Contact
Company Name: Hawk Point Media
Contact Person: Editorial Dept.
Email: info@hawkpointmedia.com
Country: United States
Website: https://hawkpointmedia.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Brenmiller Energy: A Thermal Energy Storage Play Hiding in Plain Sight ($BNRG)

Kiwi Imprints Expands Custom Branding Capabilities in Plano with New Equipment and Design Services

Kiwi Imprints, a leader in personalized branding and promotional products, has announced the expansion of its operations in Plano, Texas. The company has invested in state-of-the-art production equipment and expanded its design team to better serve local businesses, schools, and organizations seeking high-quality custom signage and apparel.

With the growing demand for unique branding materials in the North Texas market, Kiwi Imprints is positioning itself as a comprehensive solution for clients who need fast, professional, and affordable customization. The business specializes in various services, including apparel printing, vinyl signage, embroidery, and business branding packages tailored to startups and established companies.

This latest expansion includes upgraded technology for creating signs Plano businesses use to stand out in highly competitive environments. The improvements allow Kiwi Imprints to produce large-scale outdoor and indoor signage with greater speed and precision, enhancing visibility for storefronts, events, and public-facing campaigns.

Additionally, the company is expanding its textile division to meet the increased interest in embroidery, Plano schools and corporate teams rely on for logos, uniforms, and spirit wear. By integrating newer machines and expanding design consultations, Kiwi Imprints is improving quality while reducing turnaround times.

In response to a growing need for storefront visibility and promotional messaging, Kiwi Imprints is also broadening its services for window signs Plano retailers are increasingly using for seasonal promotions, sales events, and branding. The company offers customized solutions for all window sizes and materials, including perforated vinyl and UV-resistant film.

Founded on the principle of local creativity and professional service, Kiwi Imprints continues to serve as a trusted partner for businesses in Plano and surrounding areas. The company’s expanded services underscore its commitment to innovation, quality, and local economic growth.

For more information about their services and the company, please contact (972) 423-2730 or visit their website at https://kiwiimprints.com/

Media Contact
Company Name: Kiwi Imprints (Artistic Textile) – Best Signs, TShirts, Embroidery and more
Contact Person: Javed Memon
Email: Send Email
Phone: (972) 423-2730
Address:1111 Summit Ave STE 7
City: Plano
State: TX 75074
Country: United States
Website: https://kiwiimprints.com/

EnJoyPay Featured at Money20/20 Asia Bangkok

From April 22 to 24, EnJoyPay showcased at Asia’s top fintech conference Money20/20 Asia (booth K20), presenting global payment solutions to explore Southeast Asian market opportunities with global game developers, financial institutions, and cross-border ecosystem partners.

On-site booth snapshot

The EnJoyPay team engaged in cooperation discussions with financial companies, payment channels, and game developers from around the world, jointly exploring player payment experience optimization and global compliance deployment.

Currently, EnJoyPay holds Hong Kong MSO, Canada MSB, US MSB licenses, and PCI certification qualifications, offering stable compliance credentials and professional risk control. Building on this foundation, EnJoyPay provides over 500 payment solutions globally, covering more than 80 major countries and regions, supporting over 30 local languages, with advantages in regions including Japan, Korea, Southeast Asia, Latin America, and more. The aim is to maximize the global value of gaming products. By expanding regional influence, EnJoyPay assists overseas gaming companies in strengthening local payment deployment depth, increasing transaction volume and revenue, while helping reduce comprehensive channel costs to achieve commercial success in global markets.

Partnering with EnJoyPay to Unlock New Potential in Southeast Asian Game Globalization

EnJoyPay’s payment channels in Southeast Asia have been fully established and continue to be improved. With a profound understanding and rich experience in Southeast Asian local payment markets, EnJoyPay provides game companies with seamlessly integrated payment systems, ensuring efficient and secure payment services. In addition to technical support, EnJoyPay also offers market insights and operational advice to partners, comprehensively assisting enterprises in deepening their presence in Southeast Asian markets.

At Money20/20 Asia, a global stage, EnJoyPay identified new opportunities for digital content to go global. The company looks forward to working with more partners to explore blue ocean opportunities in the Southeast Asian gaming market. EnJoyPay will continuously optimize payment solutions, supporting Chinese gaming companies’ development from commercial monetization to user operations.

June is Coming: EnJoyPay Invites Global Gaming Partners to Money20/20 Europe in the Netherlands

Money20/20 is a top global fintech conference, with its European event known as the “weathervane of payment innovation,” gathering international giants like Visa and more than 5,000 financial institutions, focusing on cross-border payments, open banking, and other core topics. The 2025 exhibition will be held at the RAI Amsterdam Convention Centre, injecting global resources into the European market.

From June 3 to 5 in Amsterdam, Netherlands, at Booth K16 – EnJoyPay welcomes global gaming partners to visit and exchange ideas.

European Market Scale: Newzoo data shows that the European gaming market will exceed €36 billion by 2025, with Germany, the UK, and France contributing over 60% share.

Player Paying Power: European players’ ARPU reaches €45 (global average €28), with credit card payments accounting for over 65%.

Compliance Threshold: EU PSD2 regulations mandate payment institutions to implement SCA (Strong Customer Authentication). EnJoyPay partners with European licensed entities to help companies quickly achieve compliance.

As a compliance expert in the field of game cross-border payments, and based on Hong Kong MSO, Canada MSB, US MSB licenses, and PCI DSS certification, EnJoyPay provides gaming companies with the following core services:

Global Payment Network: Supporting international card organizations like Visa and Mastercard, covering mainstream payment methods for European and American players, increasing transaction success rates by 25%.

Compliance Risk Control System: PCI DSS-certified data encryption technology ensures zero leakage of player payment information, meeting EU GDPR and other privacy regulations.

Localized Operation Solutions: One-on-one consultation, customized rate plans, and practical strategies on how to increase European players’ payment success rates by 25%.

About EnJoyPay

EnJoyPay is a global game local payment expert, providing professional and intelligent global payment solutions for overseas game and application developers, helping them quickly and safely penetrate global markets. It has now become a global payment partner for many overseas developers.

EnJoyPay has offices in five core cities: Beijing, Shanghai, Hangzhou, Guangzhou, and Hong Kong. In Europe, the company also has a professional and diverse employee team, experienced and highly compliant. EnJoyPay deeply invests resources and establishes multiple touchpoints, committed to creating excellent business and delivering value to customers.

EnJoyPay actively participates in internationally renowned exhibitions, including the Singapore FinTech Festival and Tokyo Game Show, comprehensively covering the market, fully demonstrating business advantages, and effectively enhancing the brand’s recognition and influence among overseas user groups.

LinkedIn: EnJoyPay

WeChat: enjoykjzs

Media Contact
Company Name: EnJoyPay
Contact Person: Liu Shuiyoulan
Email: Send Email
Country: Thailand
Website: https://enjoypayment.com/

Milford Precision Tile Rebuilds Failing Shower in Darien, CT with Industry-Leading Waterproofing System

Shower Tile Installation Failure

When a homeowner in Darien, CT noticed water stains forming on their dining room ceiling, it became clear that their upstairs shower was leaking — and the damage was getting worse.

Milford, CT – When a homeowner in Darien, CT noticed water stains forming on their dining room ceiling, it became clear that their upstairs shower was leaking — and the damage was getting worse. They turned to Milford Precision Tile, a local tile installation specialist, for help. The result: a full tear-out and expert rebuild using the Schluter® waterproof shower installation system, giving the homeowner peace of mind and a brand-new, modern shower built to last.

According to Milford Precision Tile, there are no shortcuts or “quick fixes” when it comes to water leaks behind tile. “Once moisture gets behind the surface, it compromises the entire system,” said the company’s owner. “You have to remove everything and rebuild it properly — otherwise the problem will just keep coming back.”

The original shower, installed by a different contractor, had no proper waterproofing behind the tile. This allowed water to seep into the framing and subfloor, eventually leaking into the ceiling below. Milford Precision Tile’s team removed the entire enclosure down to the studs, repaired the damage, and rebuilt the shower using a complete Schluter® waterproofing system — widely considered the gold standard in the tile industry.

Along with waterproofing, the rebuild included updated ceramic tile shower installation, upgraded plumbing fixtures, mold-resistant grout, and professional sealing. The result was a leak-proof, visually stunning shower that brought both relief and style to the homeowner.

Milford Precision Tile has over 20 years of experience specializing in custom tile showers, backsplashes, and floor installations across Milford, Darien, and the surrounding Connecticut shoreline communities.

“We don’t believe in band-aid solutions. If a shower is failing, we give our clients a clean slate and build something they can trust for decades.”

The company is currently offering free consultations for homeowners concerned about shower leaks, cracked tiles, or aging bathrooms.

To schedule a consultation, call (203) 479-0140‬.

About Milford Precision Tile:

Milford Precision Tile is a locally owned tile installation company specializing in high-quality, long-lasting tile work for showers, kitchens, and floors. Known for expert craftsmanship and precision waterproofing, the company serves homeowners throughout Milford, CT and surrounding areas.

Media Contact
Company Name: Milford Precision Tile
Contact Person: Dan
Email: Send Email
Phone: (203) 479-0140?
City: Milford
State: Connecticut
Country: United States
Website: www.milfordprecisiontile.com/ceramic-tile-shower-installation-darien-ct/